APC’s Scott Brunner and Tenille Davis are guests on the latest GameChangers Pharmacotherapy...
This Wall Street Journal podcast, the second in a four-part series WSJis doing on GLP-1s, features APC CEO Scott Brunner (well, briefly). Compounding is represented reasonably fairly in their coverage here. The entire series is worth your time.